Q3 Earnings: BP Record Profits, AstraZeneca Beats
BP reported record-breaking Q3 profits on elevated fuel prices, with adjusted net income of $8.46B vs. $7.26B expected. AstraZeneca also beat estimates across the board and reconfirmed full-year guidance.
What we know
@FT headlined BP's record profit surge, confirmed by an account on X with adjusted EPS of 54.37c vs. 46.39c est. and operating cash flow of $14.83B vs. $13.32B est., though net debt of $13.9B came in slightly better than expected. AstraZeneca posted core EPS of $2.79 vs. $2.62 est. on revenue of $16.21B vs. $15.98B est., with a core operating margin of 36% vs. 33.6% est., and reconfirmed guidance. NatWest was roughly in-line with pretax profit of £2.23B vs. £2.2B est. Tesco also announced it will sell its Czech and Slovak operations for €1.7B.
Sources
“BP's profits surge to record on back of high fuel prices”
View post →By the Global Eye 24 desk, with AI assistance. Updated as the story develops. Spot an error? Write to corrections@globaleye24.com.